Ferris Capital’s Bristol-Myers Squibb BMY Stock Holding History

Ferris Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$765K	Sell	10,470 -26	-0.2%	-$1.75K	0.18%	110
2021 Q4	$654K	Sell	10,496 -79	-0.7%	-$4.63K	0.14%	121
2021 Q3	$626K	Buy	+10,575	New	+$696K	0.13%	128
2021 Q2	–	Sell	-10,375	Closed	-$655K	–	66
2021 Q1	$655K	Sell	10,375 -1,185	-10%	-$73.7K	0.16%	111
2020 Q4	$717K	Sell	11,560 -779	-6%	-$47.9K	0.2%	107
2020 Q3	$744K	Buy	12,339 +140	+1%	+$8.43K	0.24%	91
2020 Q2	$717K	Buy	12,199 +126	+1%	+$7.54K	0.25%	92
2020 Q1	$673K	Buy	12,073 +37	+0.3%	+$2.26K	0.3%	79
2019 Q4	$773K	Buy	12,036 +3,171	+36%	+$182K	0.27%	86
2019 Q3	$450K	Hold	8,865	–	–	0.16%	114
2019 Q2	$402K	Sell	8,865 -306	-3%	-$14.3K	0.15%	123
2019 Q1	$438K	Hold	9,171	–	–	0.16%	117
2018 Q4	$477K	Hold	9,171	–	–	0.21%	103
2018 Q3	$569K	Sell	9,171 -176	-2%	-$10.4K	0.22%	88
2018 Q2	$517K	Sell	9,347 -16	-0.2%	-$864	0.22%	89
2018 Q1	$592K	Buy	9,363 +41	+0.4%	+$2.64K	0.24%	84
2017 Q4	$571K	Buy	+9,322	New	+$583K	0.2%	103
2017 Q3	–	Sell	-1,722	Closed	-$96K	–	207
2017 Q2	$96K	Buy	+1,722	New	+$93.7K	0.05%	196

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ferris Capital's BMY Position: Q1 2022 in Review

Ferris Capital reduced its Bristol-Myers Squibb (BMY) stake by 0.25% in Q1 2022, selling an estimated $1.75K and leaving 10,470 shares worth $765K. The position accounts for 0.18% of the portfolio, ranked #110.

Ferris Capital first reported a position in BMY in Q2 2017 and has held it in 18 quarters since. The position peaked at $773K in Q4 2019. 2,516 funds tracked by Wall St. Rank hold BMY as of Q1 2022.

Ferris Capital held 10,470 shares of Bristol-Myers Squibb worth $765K as of Q1 2022.
Ferris Capital sold 26 Bristol-Myers Squibb shares in Q1 2022, an estimated $1.75K.
Bristol-Myers Squibb made up 0.18% of Ferris Capital's portfolio in Q1 2022, its #110 holding.
Ferris Capital first reported a position in Bristol-Myers Squibb in Q2 2017 and has held it in 18 quarters since.
Ferris Capital's Bristol-Myers Squibb position peaked at $773K in Q4 2019.
2,516 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.

Based on Ferris Capital's 13F filing for Q1 2022, filed 13 May 2022.